Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Total 13F shares
-
31,216,768
-
Share change
-
+403,623
-
Total reported value
-
$4,636,684,730
-
Put/Call ratio
-
362%
-
Price per share
-
$148.55
-
Number of holders
-
262
-
Value change
-
+$60,178,388
-
Number of buys
-
116
-
Number of sells
-
112
Institutional Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2022
As of 31 Mar 2022,
CONMED Corp - Common Stock (CNMD) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,216,768 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, EARNEST PARTNERS LLC, Champlain Investment Partners, LLC, AMERIPRISE FINANCIAL INC, Capital Research Global Investors, STATE STREET CORP, JPMORGAN CHASE & CO, LOOMIS SAYLES & CO L P, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
263
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.